Prospective review of 30-day morbidity and mortality in a paediatric neurosurgical unit [PDF]
, 2017 Purpose: The purpose of this study is to record the 30-day and inpatient morbidity and mortality in paediatric patients in a tertiary neuroscience centre over a 2-year period.
Beez, Thomas +2 more
core +2 more sources
Scientific Reports, 2022 Microscopic colitis (MC) is a chronic inflammatory bowel disease that is characterized by nonbloody watery diarrhea. The epidemiology in Japan differs from that in Europe and the United States, but little information is available from epidemiological ...
Kaito Yamashiro +9 more
doaj +1 more source
Action following the discovery of a global association between the whole genome and adverse event risk in a clinical drug-development programme [PDF]
, 2008 Observation of adverse drug reactions during drug development can cause closure of the whole programme. However, if association between the genotype and the risk of an adverse event is discovered, then it might suffice to exclude patients of certain ...
Breiman +21 more
core +1 more source
Adverse event reporting in intervention research for young autistic children
Autism, 2020 Our team examined 150 reports on group-design, non-pharmacological interventions for young autistic children, to determine the prevalence of adverse event reporting.
K. Bottema‐Beutel +3 more
semanticscholar +1 more source
Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database. [PDF]
PLoS ONE, 2017 Combined estrogen-progestin preparations (CEPs) are associated with thromboembolic (TE) side effects. The aim of this study was to evaluate the incidence of TE using the Japanese Adverse Drug Event Report (JADER) database.
Shiori Hasegawa +12 more
doaj +1 more source
Reporting of Clinical Adverse Events Scale: a measure of doctor and nurse attitudes to adverse event reporting [PDF]
, 2008 Objective: To develop a validated measure of professionals' attitudes towards clinical adverse event reporting (CAER). Design: Cross-sectional survey with follow-up. Participants: 201 doctors and nurse/nurse-midwives undergoing postqualification training
Bekker, H.L., Fylan, F., Wilson, B.
core +2 more sources
European Journal of Preventive Cardiology, 2020 AIMS The aim of this study was to characterise clinical priority of adverse events with sacubitril/valsartan for targeting preventive measures.
Milo Gatti +4 more
semanticscholar +1 more source
BMC Pharmacology and Toxicology, 2020 Background To describe and analyze the patterns of adverse events associated with dipeptidyl peptidase-4 inhibitors (DPP-4is) (sitagliptin, saxagliptin, linagliptin, vildagliptin, and alogliptin) from the FDA Adverse Event Reporting System (FAERS) and to
Jing Huang +3 more
semanticscholar +1 more source
Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and Canada. [PDF]
, 2015 This survey analyzes two national pharmacovigilance databases in order to determine the major adverse reactions observed with the use of cholinesterase inhibitors in dementia.
Abagyan, Ruben +4 more
core +3 more sources
Darbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated with cancer chemotherapy. [PDF]
, 2002 In part A of this study, patients were randomised to cohorts receiving darbepoetin alfa at doses of 0.5 to 8.0 m.c.g x kg(-1) x wk(-1) or to a control group receiving epoetin alfa at an initial dose of 150 U x kg(-1) three times weekly.
Armstrong, S +10 more
core +2 more sources